Donate

Innovation and Research

Sheba Medical Center is one of the most important innovators of health technology, not only in Israel, but globally.

The future of medical care is being created at Sheba Medical Center.

Through its ARC Innovation Center, Sheba leads the digital healthcare revolution and is the largest launch pad and ecosystem for healthcare innovation and development in Israel.

By challenging the status quo and transforming the standard hospital ecosystem, Sheba is ushering in a new era of seamless integration between innovators, scientists, startups, high level developers, large corporations, investors and academia – all to ultimately better serve its patients and develop breakthrough cures and treatments


Incubating Ideas

Sheba has created one of the world’s leading MedTech innovation platforms.

Sheba offers one of the world’s largest and best medical centers as a place to innovate and test new ideas and technologies. Against the backdrop of Israel’s entrepreneur-driven tech society, they invite inventors and entrepreneurs from around the country to come and get venture funding, mentorship, technical and scientific assistance, and a place to test their ideas and inventions.

As a result, with more than 100 start-ups in its incubator, Sheba originates 20 biomedical patent applications per year.

An example of Sheba’s creative approach is the Nexus program.

Sheba takes graduates of the most elite intelligence tech units in the IDF. The candidates are placed with physicians, therapists and other caregivers to be shadowed almost literally 24 hours a day. The IDF vets observe how the medical professionals work, what they have and what they lack.

And then they are challenged to come up with devices, software and processes that can be solutions. And when great ideas emerge, the program gives them the support, financing and direction to bring the products to market.

Innovating in fields such as big data, telemedicine, virtual reality, artificial intelligence, surgical innovation, and rehabilitation, Sheba’s goal is to rapidly introduce these advances into the market and patients’ hands as quickly as possible.

There are already high-tech medical products for retail sale in the US that were incubated at Sheba with more to come, plus those being used by hospitals and doctor’s offices.


Israel is Coming to Chicago

The best of Israeli medical technology is coming to Chicago to address healthcare inequality.

The most ambitious project Israel has ever undertaken on US soil will rise on the site of former Michael Reese Hospital, and our healthcare will be forever changed for the better.

Learn More


Eytan Stibbe Became Israel’s 2nd Astronaut

Stibbe, a former fighter pilot, blasted off from Cape Canaveral aboard a SpaceX Dragon capsule headed for the International Space Station.

He carried out some 35 experiments for companies and research institutions on his privately-funded “Rakia” (as it’s known in Hebrew) Mission to the ISS.

“The ARC Space Lab is a first of its kind initiative to harness the opportunities of new space endeavors to promote health care innovation and benefit humans in space and on Earth,” said Dr. Harel Baris, who heads the ARC Space Lab.

Read the Full Story

tech-innovation

A Pioneer in Virtual Medicine

Sheba has 42,000 telemedicine appointments annually and growing, as the hospital without boundaries expands its care virtually and to countries around the world.

Latest Research


BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers

January 12, 2022

Yaniv Lustig 1 , Einav Sapir 2 , Gili Regev-Yochay 2 , Carmit Cohen 3 , Ronen Fluss 4 , Liraz Olmer 4 , Victoria Indenbaum 5 , Michal Mandelboim […]

Read More


COVID vaccine does not cause infertility, Israeli study finds

January 5, 2022

Since the Pfizer-BioNTech vaccine was approved for use, there have been rumors that it can affect women’s fertility. Some anti-vaccine activists have espoused these claims. COVID vaccines do not affect […]

Read More


Tel Aviv University breakthrough touted as key to reversing ALS

December 15, 2021

Israeli researchers say they used experimental molecule to break down protein whose buildup can cause the debilitating condition, also known as Lou Gehrig’s Disease Israeli researchers announced Tuesday that they […]

Read More


Contribution of clinical breast exam to cancer detection in women participating in a modern screening program

October 19, 2021

Purpose Despite the controversy surrounding the role of clinical breast exam (CBE) in modern breast cancer screening, it is widely practiced. We examined the contribution of CBE in women undergoing […]

Read More


Risk factors and mortality in patients with pneumonia and elevated troponin levels

December 10, 2020

Abstract Pneumonia in hospitalized patients is associated with myocardial injury. In this study, we evaluated risk factors for myocardial injury in hospitalized patients with pneumonia and its prognostic value. We […]

Read More


Digital Cardiac Rehabilitation Programs: The Future of Patient-Centered Medicine

January 7, 2020

Background The low participation rate in cardiac rehabilitation programs is the major reason for rehospitalization, morbidity, and mortality. Home-based cardiac rehabilitation by technological means is an essential component of a […]

Read More


Emergency Department Triage in the Era of COVID-19: The Sheba Medical Center Experience.

January 1, 2020

Background Sheba Medical Center, Tel Hashomer, is a tertiary hospital located in the center of Israel. It is the largest hospital in Israel and was the first to face coronavirus […]

Read More


Advanced virtual reality-based rehabilitation of balance and gait in clinical practice

August 23, 2019

Background Extensive research shows that virtual reality (VR) enhances motor learning and has advantages in balance and gait rehabilitation of neurological patients. There is still uncertainty, however, as for the […]

Read More


Risk of early, intermediate, and late rejection following heart transplantation

July 28, 2017

Risk of early, intermediate, and late rejection following heart transplantation: Trends over the past 25 years and relation to changes in medical management. Tertiary center experience: The Sheba Heart Transplantation […]

Read More


Blood pressure control in type 2 diabetic patients

January 6, 2017

Abstract Diabetes mellitus (DM) and essential hypertension are common conditions that are frequently present together. Both are considered risk factors for cardiovascular disease and microvascular complications and therefore treatment of […]

Read More


Support Innovation.

Help Sheba Medical Center continue to expand its reach technologically and globally.

Donate Now